Intrinsic value of Invitae - NVTA

Previous Close

$12.11

  Intrinsic Value

$0.14

stock screener

  Rating & Target

str. sell

-99%

Previous close

$12.11

 
Intrinsic value

$0.14

 
Up/down potential

-99%

 
Rating

str. sell

We calculate the intrinsic value of NVTA stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.8

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  60.00
  54.50
  49.55
  45.10
  41.09
  37.48
  34.23
  31.31
  28.68
  26.31
  24.18
  22.26
  20.53
  18.98
  17.58
  16.32
  15.19
  14.17
  13.26
  12.43
  11.69
  11.02
  10.42
  9.87
  9.39
  8.95
  8.55
  8.20
  7.88
  7.59
Revenue, $m
  109
  169
  252
  366
  516
  710
  953
  1,251
  1,610
  2,033
  2,525
  3,087
  3,721
  4,427
  5,205
  6,055
  6,975
  7,963
  9,019
  10,140
  11,325
  12,572
  13,882
  15,253
  16,684
  18,177
  19,732
  21,350
  23,032
  24,780
Variable operating expenses, $m
  159
  241
  356
  513
  721
  987
  1,323
  1,734
  2,229
  2,813
  3,483
  4,259
  5,133
  6,107
  7,181
  8,354
  9,623
  10,986
  12,443
  13,989
  15,624
  17,346
  19,152
  21,044
  23,019
  25,079
  27,224
  29,456
  31,776
  34,188
Fixed operating expenses, $m
  92
  94
  96
  98
  100
  103
  105
  107
  109
  112
  114
  117
  119
  122
  125
  127
  130
  133
  136
  139
  142
  145
  148
  152
  155
  158
  162
  166
  169
  173
Total operating expenses, $m
  251
  335
  452
  611
  821
  1,090
  1,428
  1,841
  2,338
  2,925
  3,597
  4,376
  5,252
  6,229
  7,306
  8,481
  9,753
  11,119
  12,579
  14,128
  15,766
  17,491
  19,300
  21,196
  23,174
  25,237
  27,386
  29,622
  31,945
  34,361
Operating income, $m
  -142
  -166
  -200
  -245
  -305
  -380
  -475
  -590
  -729
  -892
  -1,073
  -1,289
  -1,532
  -1,803
  -2,101
  -2,426
  -2,778
  -3,156
  -3,560
  -3,989
  -4,442
  -4,919
  -5,419
  -5,943
  -6,490
  -7,060
  -7,654
  -8,271
  -8,914
  -9,581
EBITDA, $m
  -123
  -142
  -168
  -203
  -248
  -305
  -376
  -464
  -568
  -691
  -834
  -997
  -1,180
  -1,384
  -1,609
  -1,854
  -2,119
  -2,403
  -2,707
  -3,030
  -3,370
  -3,729
  -4,106
  -4,500
  -4,911
  -5,340
  -5,787
  -6,252
  -6,735
  -7,237
Interest expense (income), $m
  0
  6
  12
  22
  35
  54
  78
  109
  148
  197
  254
  323
  402
  493
  595
  709
  835
  972
  1,120
  1,280
  1,450
  1,631
  1,822
  2,024
  2,235
  2,457
  2,688
  2,929
  3,180
  3,441
  3,712
Earnings before tax, $m
  -147
  -178
  -222
  -281
  -358
  -458
  -584
  -739
  -925
  -1,146
  -1,396
  -1,691
  -2,025
  -2,398
  -2,810
  -3,261
  -3,750
  -4,277
  -4,840
  -5,439
  -6,073
  -6,741
  -7,443
  -8,178
  -8,946
  -9,747
  -10,582
  -11,451
  -12,354
  -13,293
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -147
  -178
  -222
  -281
  -358
  -458
  -584
  -739
  -925
  -1,146
  -1,396
  -1,691
  -2,025
  -2,398
  -2,810
  -3,261
  -3,750
  -4,277
  -4,840
  -5,439
  -6,073
  -6,741
  -7,443
  -8,178
  -8,946
  -9,747
  -10,582
  -11,451
  -12,354
  -13,293

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  276
  427
  638
  926
  1,307
  1,797
  2,412
  3,167
  4,075
  5,147
  6,392
  7,815
  9,419
  11,207
  13,177
  15,329
  17,657
  20,160
  22,832
  25,670
  28,670
  31,829
  35,144
  38,614
  42,239
  46,019
  49,955
  54,050
  58,309
  62,735
Adjusted assets (=assets-cash), $m
  276
  427
  638
  926
  1,307
  1,797
  2,412
  3,167
  4,075
  5,147
  6,392
  7,815
  9,419
  11,207
  13,177
  15,329
  17,657
  20,160
  22,832
  25,670
  28,670
  31,829
  35,144
  38,614
  42,239
  46,019
  49,955
  54,050
  58,309
  62,735
Revenue / Adjusted assets
  0.395
  0.396
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
  0.395
Average production assets, $m
  76
  118
  177
  256
  361
  497
  667
  876
  1,127
  1,423
  1,767
  2,161
  2,604
  3,099
  3,644
  4,238
  4,882
  5,574
  6,313
  7,098
  7,927
  8,801
  9,717
  10,677
  11,679
  12,724
  13,813
  14,945
  16,122
  17,346
Working capital, $m
  -24
  -37
  -55
  -79
  -112
  -154
  -207
  -271
  -349
  -441
  -548
  -670
  -807
  -961
  -1,130
  -1,314
  -1,513
  -1,728
  -1,957
  -2,200
  -2,457
  -2,728
  -3,012
  -3,310
  -3,621
  -3,944
  -4,282
  -4,633
  -4,998
  -5,377
Total debt, $m
  97
  173
  280
  426
  619
  866
  1,178
  1,560
  2,019
  2,562
  3,192
  3,911
  4,723
  5,628
  6,625
  7,713
  8,892
  10,158
  11,510
  12,946
  14,464
  16,063
  17,740
  19,496
  21,330
  23,243
  25,234
  27,307
  29,461
  31,701
Total liabilities, $m
  140
  216
  323
  469
  661
  909
  1,220
  1,603
  2,062
  2,605
  3,234
  3,954
  4,766
  5,671
  6,668
  7,756
  8,935
  10,201
  11,553
  12,989
  14,507
  16,105
  17,783
  19,539
  21,373
  23,285
  25,277
  27,350
  29,504
  31,744
Total equity, $m
  137
  211
  315
  458
  646
  888
  1,192
  1,565
  2,013
  2,543
  3,158
  3,860
  4,653
  5,536
  6,510
  7,572
  8,723
  9,959
  11,279
  12,681
  14,163
  15,723
  17,361
  19,075
  20,866
  22,733
  24,678
  26,701
  28,805
  30,991
Total liabilities and equity, $m
  277
  427
  638
  927
  1,307
  1,797
  2,412
  3,168
  4,075
  5,148
  6,392
  7,814
  9,419
  11,207
  13,178
  15,328
  17,658
  20,160
  22,832
  25,670
  28,670
  31,828
  35,144
  38,614
  42,239
  46,018
  49,955
  54,051
  58,309
  62,735
Debt-to-equity ratio
  0.710
  0.820
  0.890
  0.930
  0.960
  0.980
  0.990
  1.000
  1.000
  1.010
  1.010
  1.010
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
  1.020
Adjusted equity ratio
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494
  0.494

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -147
  -178
  -222
  -281
  -358
  -458
  -584
  -739
  -925
  -1,146
  -1,396
  -1,691
  -2,025
  -2,398
  -2,810
  -3,261
  -3,750
  -4,277
  -4,840
  -5,439
  -6,073
  -6,741
  -7,443
  -8,178
  -8,946
  -9,747
  -10,582
  -11,451
  -12,354
  -13,293
Depreciation, amort., depletion, $m
  19
  24
  32
  43
  57
  75
  98
  127
  160
  201
  239
  292
  352
  419
  492
  573
  660
  753
  853
  959
  1,071
  1,189
  1,313
  1,443
  1,578
  1,719
  1,867
  2,020
  2,179
  2,344
Funds from operations, $m
  -129
  -154
  -190
  -238
  -301
  -383
  -486
  -612
  -765
  -946
  -1,157
  -1,399
  -1,673
  -1,979
  -2,318
  -2,688
  -3,090
  -3,524
  -3,987
  -4,480
  -5,002
  -5,552
  -6,130
  -6,735
  -7,368
  -8,028
  -8,716
  -9,431
  -10,176
  -10,949
Change in working capital, $m
  -9
  -13
  -18
  -25
  -33
  -42
  -53
  -65
  -78
  -92
  -107
  -122
  -138
  -153
  -169
  -184
  -200
  -214
  -229
  -243
  -257
  -271
  -284
  -297
  -311
  -324
  -337
  -351
  -365
  -379
Cash from operations, $m
  -120
  -141
  -172
  -213
  -269
  -341
  -433
  -547
  -687
  -854
  -1,050
  -1,277
  -1,535
  -1,826
  -2,149
  -2,504
  -2,891
  -3,309
  -3,758
  -4,237
  -4,745
  -5,281
  -5,846
  -6,438
  -7,057
  -7,704
  -8,378
  -9,080
  -9,811
  -10,570
Maintenance CAPEX, $m
  -6
  -10
  -16
  -24
  -35
  -49
  -67
  -90
  -118
  -152
  -192
  -239
  -292
  -352
  -419
  -492
  -573
  -660
  -753
  -853
  -959
  -1,071
  -1,189
  -1,313
  -1,443
  -1,578
  -1,719
  -1,867
  -2,020
  -2,179
New CAPEX, $m
  -29
  -42
  -58
  -80
  -105
  -135
  -170
  -209
  -251
  -296
  -344
  -393
  -444
  -494
  -545
  -595
  -644
  -692
  -739
  -785
  -829
  -873
  -917
  -960
  -1,002
  -1,045
  -1,088
  -1,132
  -1,177
  -1,224
Cash from investing activities, $m
  -35
  -52
  -74
  -104
  -140
  -184
  -237
  -299
  -369
  -448
  -536
  -632
  -736
  -846
  -964
  -1,087
  -1,217
  -1,352
  -1,492
  -1,638
  -1,788
  -1,944
  -2,106
  -2,273
  -2,445
  -2,623
  -2,807
  -2,999
  -3,197
  -3,403
Free cash flow, $m
  -155
  -193
  -246
  -317
  -408
  -525
  -670
  -846
  -1,056
  -1,303
  -1,587
  -1,909
  -2,271
  -2,672
  -3,112
  -3,591
  -4,107
  -4,661
  -5,250
  -5,874
  -6,533
  -7,226
  -7,951
  -8,710
  -9,502
  -10,327
  -11,186
  -12,079
  -13,008
  -13,972
Issuance/(repayment) of debt, $m
  53
  76
  107
  146
  193
  248
  311
  382
  460
  542
  630
  720
  812
  905
  997
  1,088
  1,178
  1,266
  1,352
  1,436
  1,518
  1,598
  1,678
  1,756
  1,834
  1,913
  1,992
  2,072
  2,155
  2,240
Issuance/(repurchase) of shares, $m
  199
  253
  326
  423
  546
  700
  888
  1,112
  1,374
  1,676
  2,010
  2,394
  2,818
  3,281
  3,783
  4,324
  4,901
  5,513
  6,160
  6,841
  7,555
  8,302
  9,081
  9,892
  10,737
  11,615
  12,527
  13,474
  14,458
  15,480
Cash from financing (excl. dividends), $m  
  252
  329
  433
  569
  739
  948
  1,199
  1,494
  1,834
  2,218
  2,640
  3,114
  3,630
  4,186
  4,780
  5,412
  6,079
  6,779
  7,512
  8,277
  9,073
  9,900
  10,759
  11,648
  12,571
  13,528
  14,519
  15,546
  16,613
  17,720
Total cash flow (excl. dividends), $m
  96
  136
  187
  252
  330
  423
  529
  647
  777
  916
  1,054
  1,205
  1,358
  1,514
  1,668
  1,821
  1,971
  2,119
  2,262
  2,403
  2,540
  2,674
  2,807
  2,938
  3,069
  3,200
  3,332
  3,467
  3,605
  3,747
Retained Cash Flow (-), $m
  -199
  -253
  -326
  -423
  -546
  -700
  -888
  -1,112
  -1,374
  -1,676
  -2,010
  -2,394
  -2,818
  -3,281
  -3,783
  -4,324
  -4,901
  -5,513
  -6,160
  -6,841
  -7,555
  -8,302
  -9,081
  -9,892
  -10,737
  -11,615
  -12,527
  -13,474
  -14,458
  -15,480
Prev. year cash balance distribution, $m
  37
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -66
  -117
  -139
  -171
  -216
  -277
  -359
  -464
  -597
  -760
  -957
  -1,189
  -1,459
  -1,768
  -2,115
  -2,503
  -2,929
  -3,395
  -3,898
  -4,438
  -5,015
  -5,627
  -6,274
  -6,954
  -7,668
  -8,415
  -9,194
  -10,007
  -10,853
  -11,733
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  -63
  -107
  -121
  -141
  -167
  -201
  -242
  -290
  -343
  -399
  -454
  -508
  -555
  -593
  -621
  -636
  -637
  -625
  -600
  -564
  -519
  -467
  -411
  -354
  -298
  -246
  -197
  -155
  -118
  -88
Current shareholders' claim on cash, %
  74.6
  58.8
  48.0
  40.1
  34.2
  29.5
  25.8
  22.7
  20.1
  17.9
  16.1
  14.5
  13.1
  11.9
  10.8
  9.8
  9.0
  8.2
  7.6
  6.9
  6.4
  5.9
  5.4
  5.0
  4.6
  4.3
  4.0
  3.7
  3.4
  3.2

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders and other hereditary conditions. The Company offers panels for a range of hereditary conditions in cancer, cardiology, neuromuscular, pediatric and rare diseases. The Company focuses on genetic testing, genome network and genome management. The Company offers full gene sequencing and deletion/duplication analysis as a standard for all of its tests. The Company holds interests in AltaVoice, a patient-centered data company.

FINANCIAL RATIOS  of  Invitae (NVTA)

Valuation Ratios
P/E Ratio -5
Price to Sales 19.9
Price to Book 5
Price to Tangible Book
Price to Cash Flow -6.6
Price to Free Cash Flow -5.7
Growth Rates
Sales Growth Rate 212.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 100%
Cap. Spend. - 3 Yr. Gr. Rate 19.1%
Financial Strength
Quick Ratio 19
Current Ratio 0
LT Debt to Equity 9.1%
Total Debt to Equity 14.1%
Interest Coverage 0
Management Effectiveness
Return On Assets -69.4%
Ret/ On Assets - 3 Yr. Avg. -61.3%
Return On Total Capital -76.6%
Ret/ On T. Cap. - 3 Yr. Avg. -65.7%
Return On Equity -84.4%
Return On Equity - 3 Yr. Avg. -70.1%
Asset Turnover 0.2
Profitability Ratios
Gross Margin -12%
Gross Margin - 3 Yr. Avg. -104%
EBITDA Margin -372%
EBITDA Margin - 3 Yr. Avg. -1228.2%
Operating Margin -400%
Oper. Margin - 3 Yr. Avg. -1291.7%
Pre-Tax Margin -400%
Pre-Tax Margin - 3 Yr. Avg. -1291.7%
Net Profit Margin -400%
Net Profit Margin - 3 Yr. Avg. -1291.7%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

NVTA stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the NVTA stock intrinsic value calculation we used $68.221 million for the last fiscal year's total revenue generated by Invitae. The default revenue input number comes from 0001 income statement of Invitae. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our NVTA stock valuation model: a) initial revenue growth rate of 60% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for NVTA is calculated based on our internal credit rating of Invitae, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Invitae.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of NVTA stock the variable cost ratio is equal to 150%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $90 million in the base year in the intrinsic value calculation for NVTA stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 12.6% for Invitae.

Corporate tax rate of 27% is the nominal tax rate for Invitae. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the NVTA stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for NVTA are equal to 70%.

Life of production assets of 7.4 years is the average useful life of capital assets used in Invitae operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for NVTA is equal to -21.7%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $121.794 million for Invitae - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 69.048 million for Invitae is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Invitae at the current share price and the inputted number of shares is $0.8 billion.

RELATED COMPANIES Price Int.Val. Rating
LH Laboratory of 163.87 231.36  buy
DGX Quest Diagnost 94.71 117.37  hold
OPK OPKO Health 3.23 0.86  str.sell
NH NantHealth 1.39 0.02  str.sell
NEO NeoGenomics 16.00 2.34  str.sell
CGIX Cancer Genetic 0.540 0.04  str.sell
EXAS EXACT Sciences 68.45 110.03  str.buy

COMPANY NEWS

▶ It May Be Time to Buy Invitae   [Nov-13-18 02:48PM  GuruFocus.com]
▶ Why Invitae Corporation Is Tanking Today   [Nov-08-18 03:15PM  Motley Fool]
▶ Here's Why Invitae Lost 15.2% in October   [Nov-07-18 08:26PM  Motley Fool]
▶ Invitae: 3Q Earnings Snapshot   [05:44PM  Associated Press]
▶ Here's Why Invitae Jumped 13% in September   [Oct-11-18 07:18AM  Motley Fool]
▶ Invitae Appoints Chitra Nayak to its Board of Directors   [Sep-11-18 07:30AM  PR Newswire]
▶ Here's Why Invitae Rose 67.5% in August   [12:58AM  Motley Fool]
▶ Here's Why Invitae Corp Rose as Much as 20.6% Today   [Aug-08-18 11:40AM  Motley Fool]
▶ Invitae: 2Q Earnings Snapshot   [05:45PM  Associated Press]
▶ Invitae Corp. to Host Earnings Call   [02:30PM  ACCESSWIRE]
▶ Invitae (NVTA): Moving Average Crossover Alert   [Jul-26-18 06:34AM  Zacks]
▶ Here's Why Invitae Dropped 14.9% in 2018 (So Far)   [Jul-06-18 06:40AM  Motley Fool]
▶ Here's Why Invitae Rose as Much as 13.9% Today   [May-10-18 01:30PM  Motley Fool]
▶ Invitae: 1Q Earnings Snapshot   [May-09-18 05:19PM  Associated Press]
▶ 5 of the Best Stocks Under $10 for 2018   [May-08-18 03:28PM  Zacks]
▶ Here's Why Invitae Stock Dropped as Much as 19.6% Today   [Mar-28-18 12:07PM  Motley Fool]
▶ This Explains Why Invitae Is Sinking Today   [Mar-27-18 11:56AM  Motley Fool]
▶ 9 Stocks Moving In Monday's After-Hours Session   [Mar-26-18 05:13PM  Benzinga]
▶ 3 Top Small-Cap Stocks to Buy in February   [Feb-23-18 07:56AM  Motley Fool]
▶ Best-In-Class Growth Stocks   [Feb-15-18 11:02AM  Simply Wall St.]
▶ Here's Why Invitae Dropped as Much as 18.3% Today   [Feb-13-18 12:41PM  Motley Fool]
▶ Invitae reports 4Q loss   [Feb-12-18 04:57PM  Associated Press]
▶ Invitae Corp. to Host Earnings Call   [12:00PM  ACCESSWIRE]
▶ 3 Stocks That Could Double in the Next Decade   [Jan-17-18 06:33AM  Motley Fool]
▶ Here's Why Invitae Dropped as Much as 14.3% Today   [Jan-08-18 03:03PM  Motley Fool]
▶ My 3 Top Growth Stocks for 2018   [Jan-02-18 09:07PM  Motley Fool]
▶ Best AMEX Growth Stocks   [Dec-26-17 11:02AM  Simply Wall St.]
▶ ETFs with exposure to Invitae Corp. : December 22, 2017   [Dec-22-17 11:46AM  Capital Cube]
▶ ETFs with exposure to Invitae Corp. : December 11, 2017   [Dec-11-17 02:04PM  Capital Cube]
▶ 3 Great Stocks Under $10   [Dec-04-17 08:32AM  Motley Fool]
▶ ETFs with exposure to Invitae Corp. : December 1, 2017   [Dec-01-17 10:43AM  Capital Cube]
▶ Will Invitae Ever Turn a Profit?   [Nov-13-17 11:17AM  Motley Fool]
▶ Here's Why Invitae Rose as Much as 13.8% Today   [Nov-07-17 04:53PM  Motley Fool]
▶ Invitae reports 3Q loss   [Nov-06-17 04:42PM  Associated Press]
▶ Invitae Corp to Host Earnings Call   [08:30AM  ACCESSWIRE]
▶ ETFs with exposure to Invitae Corp. : October 23, 2017   [Oct-23-17 10:52AM  Capital Cube]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.